(Q24242955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

1 reference

title

Traditional corticosteroids for induction of remission in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

0 references

C H Seow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A M Griffiths

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

16 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

CD006792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double-blind study and follow-up.

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Sulphasalazine and prednisone compared with sulphasalazine for treating active Crohn disease. A double-blind, randomized, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

An experiment to determine the active therapeutic moiety of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Anti-inflammatory actions of steroids: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

How effective are the usual treatments for Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Assessing the quality of randomized trials: reliability of the Jadad scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

The case for using 5-aminosalicyclates in Crohn's disease: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Debate: should mesalamine be used in Crohn's disease?: comments and conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Review article: biological drugs in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Budesonide for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

The case against using 5-aminosalicyclates in Crohn's disease: con.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Cortisone in ulcerative colitis; preliminary report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

An index of inflammatory activity in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Corticosteroids in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Enteral nutritional therapy for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006792.PUB2

Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial

21 January 2018

1 reference

12 December 2020

Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease

1 reference

12 December 2020

Corticosteroids in the treatment of gastrointestinal disease

1 reference

12 December 2020

Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease

1 reference

12 December 2020

How effective are current drugs for Crohn's disease? A meta-analysis

1 reference

12 December 2020

Methotrexate for induction of remission in refractory Crohn's disease

1 reference

12 December 2020

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Development and validation of a pediatric Crohn's disease activity index

1 reference

12 December 2020

Natalizumab for induction of remission in Crohn's disease

1 reference

12 December 2020

[Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study]

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: study design and conduct of the study

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: adverse reactions to study drugs

1 reference

12 December 2020

A trial of sulfasalazine as adjunctive therapy in Crohn's disease

1 reference

12 December 2020

Use of a chronomulticorticoid in the treatment of Crohn's disease

1 reference

12 December 2020

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment

1 reference

12 December 2020

Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group

1 reference

12 December 2020

Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration

1 reference

12 December 2020

Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy

1 reference

12 December 2020

Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

1 reference

12 December 2020

10.1002/14651858.CD006792.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1016197

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1016197

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18425970%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

18425970

2 references

Consolidated OpenCitations Corpus – April 2017

1016197